184 related articles for article (PubMed ID: 33675561)
41. Clinical and Histological Characteristics of Mycosis Fungoides and Sézary Syndrome: A Retrospective, Single-centre Study of 43 Patients from Eastern Denmark.
Nielsen PR; Eriksen JO; Wehkamp U; Lindahl LM; Gniadecki R; Fogh H; Fabricius S; Bzorek M; Ødum N; Gjerdrum LM
Acta Derm Venereol; 2019 Dec; 99(13):1231-1236. PubMed ID: 31620804
[TBL] [Abstract][Full Text] [Related]
42. Clinicopathological spectrum of mycosis fungoides type cutaneous T-cell lymphoma.
Shaikh ZI; Rahman SB
J Coll Physicians Surg Pak; 2006 Mar; 16(3):171-4. PubMed ID: 16542594
[TBL] [Abstract][Full Text] [Related]
43. Predictors for the use of systemic therapy in stage IB Mycosis fungoides.
Rodriguez E; Needle CD; Martinez MJ; Nohria A; Xing Y; Song C; Betensky R; Latkowski JA; Adotama P
Arch Dermatol Res; 2024 Jun; 316(6):337. PubMed ID: 38844623
[TBL] [Abstract][Full Text] [Related]
44. Folliculotropic mycosis fungoides: clinicopathological analysis of 17 patients.
Marschalkó M; Erős N; Kontár O; Hidvégi B; Telek J; Hársing J; Jókai H; Bottlik G; Rajnai H; Szepesi Á; Matolcsy A; Kárpáti S; Csomor J
J Eur Acad Dermatol Venereol; 2015 May; 29(5):964-72. PubMed ID: 25406034
[TBL] [Abstract][Full Text] [Related]
45. Plaque stage folliculotropic mycosis fungoides: histopathologic features and prognostic factors in a series of 40 patients.
van Santen S; Jansen PM; Quint KD; Vermeer MH; Willemze R
J Cutan Pathol; 2020 Mar; 47(3):241-250. PubMed ID: 31755567
[TBL] [Abstract][Full Text] [Related]
46. Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
Scarisbrick JJ; Kim YH; Whittaker SJ; Wood GS; Vermeer MH; Prince HM; Quaglino P
Br J Dermatol; 2014 Jun; 170(6):1226-36. PubMed ID: 24641480
[TBL] [Abstract][Full Text] [Related]
47. A case of new onset keratosis pilaris after discontinuation of erlotinib.
Okereke UR; Colozza S; Cohen DE
J Drugs Dermatol; 2014 Nov; 13(11):1410-1. PubMed ID: 25607711
[TBL] [Abstract][Full Text] [Related]
48. Purely follicular mycosis fungoides without mucinosis: report of two cases with review of the literature.
Monopoli A; Annessi G; Lombardo GA; Baliva G; Girolomoni G
J Am Acad Dermatol; 2003 Mar; 48(3):448-52. PubMed ID: 12637929
[TBL] [Abstract][Full Text] [Related]
49. Interstitial mycosis fungoides: A rare presentation of mycosis fungoides with overlapping granulomatous and folliculotropic features.
Chung C; Wu B; LeWitt T; Griffin T; Hooper M; Zhou XA; Choi J; Guitart J
J Cutan Pathol; 2024 Jun; 51(6):459-467. PubMed ID: 38443749
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathologic features and T-cell receptor gene rearrangement findings of mycosis fungoides palmaris et plantaris.
Kim ST; Jeon YS; Sim HJ; Kim SH; Kim YK; Suh KS; Park JH; Park SW
J Am Acad Dermatol; 2006 Mar; 54(3):466-71. PubMed ID: 16488298
[TBL] [Abstract][Full Text] [Related]
51. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
52. Folliculotropism Does Not Affect Overall Survival in Mycosis Fungoides: Results from a Single-Center Cohort and Meta-Analysis.
Giberson M; Mourad A; Gniadecki R
Dermatology; 2017; 233(4):320-325. PubMed ID: 29169156
[TBL] [Abstract][Full Text] [Related]
53. Solitary mycosis fungoides: a distinct clinicopathologic entity with a good prognosis: a series of 15 cases and literature review.
Ally MS; Pawade J; Tanaka M; Morris S; Mitchell T; Child F; Wain M; Whittaker S; Robson A
J Am Acad Dermatol; 2012 Oct; 67(4):736-44. PubMed ID: 22533993
[TBL] [Abstract][Full Text] [Related]
54. PUVA in early mycosis fungoides may give long-term remission and delay extracutaneous spread.
Roupe G; Sandström MH; Kjellström C
Acta Derm Venereol; 1996 Nov; 76(6):475-8. PubMed ID: 8982416
[TBL] [Abstract][Full Text] [Related]
55. Papular mycosis fungoides: a new clinical variant of early mycosis fungoides.
Kodama K; Fink-Puches R; Massone C; Kerl H; Cerroni L
J Am Acad Dermatol; 2005 Apr; 52(4):694-8. PubMed ID: 15793526
[TBL] [Abstract][Full Text] [Related]
56. [Long term results of total skin electron beam therapy (TSEBT) in the treatment of mycosis fungoides].
Hagedorn M; Hasche E; Kober B; Sander CA
Hautarzt; 2003 Mar; 54(3):256-64. PubMed ID: 12634995
[TBL] [Abstract][Full Text] [Related]
57. Role of bath psoralen plus ultraviolet A in early-stage mycosis fungoides.
Pavlotsky F; Hodak E; Ben Amitay D; Barzilai A
J Am Acad Dermatol; 2014 Sep; 71(3):536-41. PubMed ID: 24836546
[TBL] [Abstract][Full Text] [Related]
58. Erythromelanosis follicularis faciei et colli: A clinicoepidemiologic study.
Arif T; Adil M; Amin SS; Tahseen M; Dorjay K; Mohtashim M; Singh M; Bansal R; Raj D
Pediatr Dermatol; 2018 Jan; 35(1):e70-e71. PubMed ID: 29164663
[TBL] [Abstract][Full Text] [Related]
59. Queratosis Pilaris.
Pediatr Dermatol; 2019 Nov; 36(6):e106-e107. PubMed ID: 31778571
[No Abstract] [Full Text] [Related]
60. [Treatment of mycosis fungoides by 308 nm excimer laser: a clinical and histological study in 10 patients].
Passeron T; Angeli K; Cardot-Leccia N; Perrin C; Lacour JP; Ortonne JP
Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 1):225-31. PubMed ID: 17389845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
